The landscape of dementia diagnosis has evolved significantly with the arrival of sophisticated biomarkers, which include amyloid PET scans, tau imaging, and blood-based exams which can detect Alzheimer's pathology many years ahead of indications emerge. Even though these technological innovations signify impressive development in understanding neu